Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on the cardiopulmonary stress testing systems market provides an in-depth analysis of
segments and sub-segments in the global as well as regional cardiopulmonary
stress testing systems market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional cardiopulmonary
stress testing systems market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of the global cardiopulmonary stress testing systems market. According to the report,
the global cardiopulmonary stress testing systems market is projected to grow
at a CAGR of 4.6% over the forecast period of 2019-2025.
The Cardiopulmonary Stress test is an evaluation of the cardiopulmonary system measuring the integrated response of the pulmonary, cardiovascular,
and muscular systems, which involves measurements of gas exchange, primarily
oxygen uptake (i.e., VO2), carbon dioxide output (VCO2), minute ventilation,
and anaerobic (lactic acid) threshold. It has become an important clinical tool
for the assessment of patients with cardiovascular and pulmonary disease. The
test is performed to a point of symptom limitation (chest pain, severe dyspnea,
pallor, faintness, inability to continue pedaling or walking) or discontinued
by medical staff in case of significant ECG abnormalities, fall in systolic or
diastolic blood pressure (BP), severe oxygen desaturation (<80%), or
achievement of maximum predicted heart rate. The cardiopulmonary exercise the testing system is increasingly being used in a wide spectrum of clinical
applications for the evaluation of the undiagnosed exercise.
As per WHO, approximately 17.9 million people die every year
due to cardiovascular diseases. The increasing cardiovascular and pulmonary
disorders are driving the cardiopulmonary stress testing systems market. On the
other hand, according to the Global Health and Wellness Report - 2018, 40% of
the USA adult population has been diagnosed with a cardiovascular condition,
which increases the demand for the market. Technology is enhancing at a rapid
speed where many systems have been revolutionized with the latest technological
advancement, which makes the cardiopulmonary stress testing systems more
accurate, valuable and reliable. This technological development propels the
market. On the other hand, the increasing number of approval of the new product
by the government authorities propel the growth of this market. For instance,
Vyaire Medical Inc has received FDA approval for its two Novel Pulmonary
Function Testing Products which runs on the easy-to-operate Sentry Suite
Software, that is Vyntus ONE and Vyntus BODY. The products offer consistent and
accurate respiratory testing that has attracted the attention of
customers. However, the high-cost associated
with the cardiopulmonary Stress test system yet remains one of the major
restraints for this market. Moreover, government initiatives and the
manufacturer's approach towards advanced technology offer favorable
opportunities in the cardiopulmonary stress testing systems market.
Based on the region, the global cardiopulmonary stress testing
systems market is segmented into North America, Asia Pacific, Europe, and ROW.
Among all, North America holds the highest market share and expected to
continue its growth in the forecast period due to the increasing adoption of
early diagnosis practices as well as rising adoption of newly introduced
advanced systems at public health institutes which aid physicians and nurses to
monitor patient’s health in real-time. In addition, the increasing number of cardiovascular
disease patients in this region boost the growth of this market. On the other
hand, Asia Pacific is expected to hold the highest market share in this market
due to the increasing air pollution has resulted in an exponential increase in
respiratory and cardiovascular diseases.
The report on the global cardiopulmonary stress testing systems
market covers segments such as product, application, and end user. On the basis
of product, the sub-markets include a pulse oximeter, stress blood pressure
monitor, and stress ECG. On the basis of application, the sub-markets include
preoperative evaluation, and stress testing in sports. On the basis of end
user, the sub-markets include hospitals, clinical diagnostic labs, and rehab
centers.
The report provides profiles of the companies in the market
such as Thermo Fisher Scientific Ltd, Philips Healthcare, Care Medical Ltd,
Cosmed Medical, Cardiac Science Corporation, GE Healthcare, TouchPoint,
Cardinal Health, NIHON KOHDEN CORPORATION, Vyaire Medical Inc., and W.L. Gore
& Associates.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of cardiopulmonary
stress testing systems market. Moreover, the study highlights current market
trends and provides forecast from 2019-2025. We also have highlighted future
trends in the market that will affect the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight into the market share of the leading players.
Please Choose One of them.